Medical Lead, UK (Hybrid) at Insulet Corporation | GB | Rezi

Medical Lead, UK (Hybrid) at Insulet Corporation

Medical Lead, UK (Hybrid)

Insulet Corporation · GB

1 weeks ago

Medical Lead, UK (Hybrid)

Insulet Corporation · GB

10 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now
Resume preview

Tailor your resume to this Medical Lead, UK (Hybrid) role.

Rezi rewrites your resume against Insulet Corporation's job description. Free.

Resume score gauge reading 58 out of 100

Don't guess if your resume is good enough.

See how it scores against the Medical Lead, UK (Hybrid) posting at Insulet Corporation — free, in seconds.

About the Role

The Medical Affairs Lead is accountable for developing and executing the Medical Affairs strategy for the United Kingdom. They lead the creation and execution of the country medical plans in alignment with the business objectives of the Insulet’s affiliate. The medical plans encompass value-generating activities on medical education, evidence generation and dissemination, HCP and KOL engagement, and internal knowledge and insights translation.

Responsibilities

  • Supervise country Medical Affairs staff focused on delivering the medical objectives for the region by providing direction, guidance and oversight of assigned projects and accountabilities
  • Develop and lead the execution of the Medical Affairs strategy at a country level through cross-functional collaboration and influence – supporting efficient go-to-market plans
  • Lead, establish and execute the local medical education plans for the UK: educate HCP with online/in-person blended offerings (on-demand, webinars, Peer-to-Peer training), deliver medical education at congresses and symposiums, support product training with generation and delivery of medical content
  • Inform & strategise evidence generation plans, in answer to fulfil market access, regulatory and marketing needs
  • Support the local execution of Insulet-sponsored and Investigator-Initiated trials
  • Build confidence and advocacy among key external influencers (KOLs)

Requirements

  • MD, PharmD, PhD or MS in life science or equivalent experience
  • Demonstrated relevant Medical Affairs experience in diabetes within the pharmaceutical or medical device industry
  • In-depth understanding of the diabetes disease state, the current/future treatment landscape, and ongoing clinical trials/research
  • Understanding of the country medical practice and clinical decision-making regarding patient care for diabetes
  • Proven leader in Medical Affairs including developing and leading the implementation of medical strategy
  • Excellent written and verbal communication skills in English
  • Broad understanding of the international commercial and regulatory environment for medical devices
  • Strong scientific acumen and attention to detail
  • Combined strategic thinking and execution skills
  • Demonstrated ability to integrate, lead and influence in a challenging cross-functional environment
  • High ethical standards which apply to interactions with HCPs, payers, and industry representatives

Skills

  • Medical Affairs strategy development and implementation
  • Cross-functional collaboration and influence
  • Medical education planning and execution
  • Evidence generation strategy
  • KOL engagement
  • Written and verbal communication
  • International commercial and regulatory environment understanding
  • Scientific acumen
  • Strategic thinking and execution
  • Leadership and influence
  • Ethical conduct

Location

  • London, United Kingdom

Work Type

  • Hybrid
  • Travel required (30-40% domestic and occasional international)

Experience Level

  • Demonstrated relevant Medical Affairs experience

Education Level

  • MD, PharmD, PhD or MS in life science or equivalent experience

About the Company

  • Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Massachusetts.
  • The company is dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform.
  • The Omnipod Insulin Management System offers a unique alternative to traditional insulin delivery methods with a simple, wearable, tubeless disposable Pod that provides up to three days of non-stop insulin delivery.
  • Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor for automated blood sugar management.
  • Insulet also leverages its Pod technology for delivering non-insulin subcutaneous drugs across other therapeutic areas.
  • The company seeks highly motivated, performance-driven individuals guided by shared values to exceed customer expectations.